Compare GSK Consumer with RADICO KHAITAN - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs RADICO KHAITAN - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER RADICO KHAITAN GSK CONSUMER/
RADICO KHAITAN
 
P/E (TTM) x 39.1 28.6 137.0% View Chart
P/BV x 11.0 4.5 245.2% View Chart
Dividend Yield % 1.0 0.3 368.0%  

Financials

 GSK CONSUMER   RADICO KHAITAN
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
RADICO KHAITAN
Mar-19
GSK CONSUMER/
RADICO KHAITAN
5-Yr Chart
Click to enlarge
High Rs7,819495 1,579.7%   
Low Rs5,832298 1,957.6%   
Sales per share (Unadj.) Rs1,136.9157.2 723.3%  
Earnings per share (Unadj.) Rs233.714.6 1,605.6%  
Cash flow per share (Unadj.) Rs248.117.7 1,398.8%  
Dividends per share (Unadj.) Rs105.001.20 8,750.0%  
Dividend yield (eoy) %1.50.3 508.2%  
Book value per share (Unadj.) Rs973.5100.1 972.3%  
Shares outstanding (eoy) m42.06133.40 31.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.02.5 238.0%   
Avg P/E ratio x29.227.2 107.2%  
P/CF ratio (eoy) x27.522.4 123.1%  
Price / Book Value ratio x7.04.0 177.1%  
Dividend payout %44.98.2 545.0%   
Avg Mkt Cap Rs m287,08352,886 542.8%   
No. of employees `0003.81.2 328.3%   
Total wages/salary Rs m6,4461,714 376.1%   
Avg. sales/employee Rs Th12,440.217,907.3 69.5%   
Avg. wages/employee Rs Th1,677.01,463.5 114.6%   
Avg. net profit/employee Rs Th2,556.71,657.9 154.2%   
INCOME DATA
Net Sales Rs m47,82020,969 228.0%  
Other income Rs m4,326133 3,255.1%   
Total revenues Rs m52,14621,102 247.1%   
Gross profit Rs m11,4103,503 325.7%  
Depreciation Rs m606424 142.7%   
Interest Rs m8355 2.2%   
Profit before tax Rs m15,1232,857 529.3%   
Minority Interest Rs m061 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,295976 542.3%   
Profit after tax Rs m9,8281,941 506.2%  
Gross profit margin %23.916.7 142.8%  
Effective tax rate %35.034.2 102.4%   
Net profit margin %20.69.3 222.0%  
BALANCE SHEET DATA
Current assets Rs m52,67412,254 429.9%   
Current liabilities Rs m18,1407,789 232.9%   
Net working cap to sales %72.221.3 339.2%  
Current ratio x2.91.6 184.6%  
Inventory Days Days3663 56.7%  
Debtors Days Days29112 26.4%  
Net fixed assets Rs m4,7987,299 65.7%   
Share capital Rs m421267 157.6%   
"Free" reserves Rs m40,52713,091 309.6%   
Net worth Rs m40,94713,357 306.5%   
Long term debt Rs m0217 0.0%   
Total assets Rs m60,68122,514 269.5%  
Interest coverage x1,939.89.1 21,428.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 84.6%   
Return on assets %16.210.2 158.9%  
Return on equity %24.014.5 165.1%  
Return on capital %37.024.1 153.3%  
Exports to sales %04.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA917 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171917 345.8%   
Fx outflow Rs m1,7700-   
Net fx Rs m1,401917 152.8%   
CASH FLOW
From Operations Rs m6,7113,087 217.4%  
From Investments Rs m-3,351-66 5,115.4%  
From Financial Activity Rs m-3,768-2,259 166.8%  
Net Cashflow Rs m-408762 -53.5%  

Share Holding

Indian Promoters % 0.0 40.5 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 9.4 8.5%  
FIIs % 12.0 19.6 61.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 30.5 48.5%  
Shareholders   26,457 37,115 71.3%  
Pledged promoter(s) holding % 0.0 22.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   VST INDUSTRIES  ITC  ZYDUS WELLNESS  SANWARIA CONSUMER  BRITANNIA  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

Burger King IPO, Auto Sales in November, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note yesterday. Benchmark indices fell more than 1% before recovering partial losses.

Related Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

RADICO KHAITAN Announces Quarterly Results (3QFY20); Net Profit Up 6.9% (Quarterly Result Update)

Jan 27, 2020 | Updated on Jan 27, 2020

For the quarter ended December 2019, RADICO KHAITAN has posted a net profit of Rs 557 m (up 6.9% YoY). Sales on the other hand came in at Rs 20 bn (down 2.3% YoY). Read on for a complete analysis of RADICO KHAITAN's quarterly results.

Burger King IPO: Should You Subscribe to This QSR Chain Business? (IPO)

Dec 2, 2020

Does the company with one of the fastest-growing QSR chains in India have sound prospects?

RADICO KHAITAN Announces Quarterly Results (2QFY20); Net Profit Up 58.6% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, RADICO KHAITAN has posted a net profit of Rs 786 m (up 58.6% YoY). Sales on the other hand came in at Rs 25 bn (up 32.2% YoY). Read on for a complete analysis of RADICO KHAITAN's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks(Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits(Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You(Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution(Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living(The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 8-QTR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS